Transcriptional orchestration of EMT: Unraveling novel molecular targets in pulmonary fibrosis.
作者信息
Bobis-Wozowicz Sylwia, Paw Milena
机构信息
Jagiellonian University, Faculty of Biochemistry, Biophysics and Biotechnology, Department of Cell Biology, Kraków, Poland.
出版信息
Mol Ther. 2024 Nov 6;32(11):3765-3767. doi: 10.1016/j.ymthe.2024.10.012. Epub 2024 Oct 28.
Abstract
摘要
相似文献
1
Transcriptional orchestration of EMT: Unraveling novel molecular targets in pulmonary fibrosis.上皮-间质转化的转录调控：揭示肺纤维化中的新型分子靶点
Mol Ther. 2024 Nov 6;32(11):3765-3767. doi: 10.1016/j.ymthe.2024.10.012. Epub 2024 Oct 28.
2
[Therapeutic mechanism of extract for post-viral pneumonia pulmonary fibrosis: a metabolomics, network pharmacology analysis and experimental verification].[病毒后肺炎肺纤维化提取物的治疗机制：代谢组学、网络药理学分析及实验验证]
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Jun 20;45(6):1185-1199. doi: 10.12122/j.issn.1673-4254.2025.06.08.
3
Disulfiram activation of prostaglandin E2 synthesis: a novel antifibrotic mechanism in pulmonary fibrosis.双硫仑激活前列腺素E2合成：肺纤维化中的一种新型抗纤维化机制。
J Pharmacol Exp Ther. 2025 Jun;392(6):103588. doi: 10.1016/j.jpet.2025.103588. Epub 2025 Apr 21.
4
Da-yuan-yin decoction alleviates bleomycin-induced pulmonary injury by inhibiting epithelial-mesenchymal transition via E-cadherin/β-catenin complex restoration.大元饮通过恢复E-钙黏蛋白/β-连环蛋白复合物抑制上皮-间质转化，从而减轻博来霉素诱导的肺损伤。
J Ethnopharmacol. 2025 Jun 14;351:120148. doi: 10.1016/j.jep.2025.120148.
5
Unraveling the therapeutic mechanisms of Bufei Yiqi decoction in pulmonary fibrosis: Modulation of autophagy and glycolysis pathways.揭示补肺益气汤治疗肺纤维化的机制：对自噬和糖酵解途径的调节
Int Immunopharmacol. 2025 Jun 23;162:115030. doi: 10.1016/j.intimp.2025.115030.
6
Novel transcripts of EMT driving the malignant transformation of oral submucous fibrosis.上皮-间质转化的新转录本驱动口腔黏膜下纤维化的恶性转化。
Sci Rep. 2025 Jan 26;15(1):3294. doi: 10.1038/s41598-025-87790-2.
7
SARS-CoV-2-encoded miR-nsp3-3p promotes pulmonary fibrosis by inhibiting expression of ALCAM.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）编码的微小RNA-nsp3-3p通过抑制激活白细胞黏附分子（ALCAM）的表达来促进肺纤维化。
Virol Sin. 2025 Jul 1. doi: 10.1016/j.virs.2025.06.007.
8
UHRF1 promotes epithelial-mesenchymal transition mediating renal fibrosis by activating the TGF-β/SMAD signaling pathway.UHRF1通过激活TGF-β/SMAD信号通路促进介导肾纤维化的上皮-间质转化。
Sci Rep. 2025 Jan 27;15(1):3346. doi: 10.1038/s41598-025-86496-9.
9
Mitochondria-Targeting SIRT3 Activator Effectively Controls Bleomycin-Induced Pulmonary Fibrosis.线粒体靶向SIRT3激活剂有效控制博来霉素诱导的肺纤维化。
Biofactors. 2025 Jul-Aug;51(4):e70032. doi: 10.1002/biof.70032.
10
Cytokines as drivers: Unraveling the mechanisms of epithelial-mesenchymal transition in COVID-19 lung fibrosis.细胞因子作为驱动因素：解析 COVID-19 肺纤维化中上皮-间充质转化的机制。
Biochem Biophys Res Commun. 2023 Dec 17;686:149118. doi: 10.1016/j.bbrc.2023.10.050. Epub 2023 Oct 14.
本文引用的文献
1
GTSE1-driven ZEB1 stabilization promotes pulmonary fibrosis through the epithelial-to-mesenchymal transition.GTSE1 驱动的 ZEB1 稳定促进肺纤维化通过上皮间质转化。
Mol Ther. 2024 Nov 6;32(11):4138-4157. doi: 10.1016/j.ymthe.2024.09.029. Epub 2024 Sep 27.
2
Lack of basic rationale in epithelial-mesenchymal transition and its related concepts.上皮-间质转化及其相关概念中缺乏基本原理。
Cell Biosci. 2024 Aug 20;14(1):104. doi: 10.1186/s13578-024-01282-w.
3
Pulmonary fibrosis: from pathogenesis to clinical decision-making.肺纤维化：从发病机制到临床决策。
Trends Mol Med. 2023 Dec;29(12):1076-1087. doi: 10.1016/j.molmed.2023.08.010. Epub 2023 Sep 14.
4
Pan-cancer analyses reveal GTSE1 as a biomarker for the immunosuppressive tumor microenvironment.泛癌症分析显示 GTSE1 可作为免疫抑制性肿瘤微环境的生物标志物。
Medicine (Baltimore). 2023 Aug 25;102(34):e34996. doi: 10.1097/MD.0000000000034996.
5
Idiopathic pulmonary fibrosis: state of the art for 2023.特发性肺纤维化：2023 年的最新进展。
Eur Respir J. 2023 Apr 20;61(4). doi: 10.1183/13993003.00957-2022. Print 2023 Apr.
6
UHRF1-mediated ferroptosis promotes pulmonary fibrosis via epigenetic repression of GPX4 and FSP1 genes.UHRF1 通过表观遗传抑制 GPX4 和 FSP1 基因促进铁死亡进而促进肺纤维化。
Cell Death Dis. 2022 Dec 24;13(12):1070. doi: 10.1038/s41419-022-05515-z.
7
Epithelial-to-Mesenchymal Transition in Fibrosis: Concepts and Targeting Strategies.纤维化中的上皮-间质转化：概念与靶向策略
Front Pharmacol. 2021 Sep 7;12:737570. doi: 10.3389/fphar.2021.737570. eCollection 2021.
8
The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders.上皮-间质转化作为纤维化疾病潜在的治疗靶点
Front Cell Dev Biol. 2020 Dec 21;8:607483. doi: 10.3389/fcell.2020.607483. eCollection 2020.
9
lncRNA ZEB1-AS1 promotes pulmonary fibrosis through ZEB1-mediated epithelial-mesenchymal transition by competitively binding miR-141-3p.长链非编码 RNA ZEB1-AS1 通过竞争性结合 miR-141-3p 介导 ZEB1 促进上皮-间充质转化从而促进肺纤维化。
Cell Death Dis. 2019 Feb 12;10(2):129. doi: 10.1038/s41419-019-1339-1.
10
A novel p53-inducible gene coding for a microtubule-localized protein with G2-phase-specific expression.一个编码微管定位蛋白且具有G2期特异性表达的新型p53诱导基因。
EMBO J. 1998 Sep 1;17(17):5015-25. doi: 10.1093/emboj/17.17.5015.
Zotero 插件